Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.9M Sell
15,817
-944
-6% -$174K 0.01% 505
2025
Q4
$2.95M Buy
16,761
+2,106
+14% +$344K 0.01% 525
2025
Q3
$2.05M Sell
14,655
-847
-5% -$114K 0.01% 579
2025
Q2
$1.95M Buy
15,502
+3,200
+26% +$399K 0.01% 630
2025
Q1
$1.68M Sell
12,302
-2,207
-15% -$316K 0.01% 670
2024
Q4
$2.22M Sell
14,509
-1,724
-11% -$291K 0.01% 637
2024
Q3
$3.15M Sell
16,233
-863
-5% -$181K 0.01% 538
2024
Q2
$3.96M Buy
17,096
+529
+3% +$115K 0.01% 471
2024
Q1
$3.57M Sell
16,567
-399
-2% -$93.4K 0.01% 493
2023
Q4
$4.39M Sell
16,966
-263
-2% -$64.6K 0.02% 445
2023
Q3
$4.43M Buy
17,229
+6
+0% +$1.6K 0.02% 425
2023
Q2
$4.91M Buy
17,223
+55
+0.3% +$16.4K 0.02% 425
2023
Q1
$4.77M Sell
17,168
-1,508
-8% -$417K 0.02% 426
2022
Q4
$5.17M Buy
18,676
+351
+2% +$99.1K 0.02% 406
2022
Q3
$4.89M Buy
18,325
+1,137
+7% +$241K 0.02% 395
2022
Q2
$3.48M Sell
17,188
-511
-3% -$104K 0.02% 434
2022
Q1
$3.73M Sell
17,699
-415
-2% -$90.2K 0.02% 419
2021
Q4
$4.35M Sell
18,114
-4,385
-19% -$1.13M 0.02% 411
2021
Q3
$6.37M Sell
22,499
-2,100
-9% -$688K 0.03% 334
2021
Q2
$8.52M Sell
24,599
-10,802
-31% -$3.27M 0.04% 293
2021
Q1
$9.9M Sell
35,401
-35,039
-50% -$9.45M 0.04% 268
2020
Q4
$17.2M Sell
70,440
-3,785
-5% -$976K 0.08% 192
2020
Q3
$21.1M Sell
74,225
-772
-1% -$215K 0.1% 159
2020
Q2
$20.1M Sell
74,997
-420
-0.6% -$126K 0.11% 156
2020
Q1
$23.9M Buy
75,417
+3,251
+5% +$987K 0.14% 136
2019
Q4
$21.4M Sell
72,166
-286
-0.4% -$79.4K 0.1% 132
2019
Q3
$16.9M Buy
72,452
+622
+0.9% +$145K 0.08% 180
2019
Q2
$16.8M Sell
71,830
-5,662
-7% -$1.31M 0.09% 181
2019
Q1
$18.3M Sell
77,492
-950
-1% -$299K 0.1% 174
2018
Q4
$23.6M Sell
78,442
-4,936
-6% -$1.58M 0.14% 144
2018
Q3
$29.5M Sell
83,378
-4,968
-6% -$1.71M 0.15% 137
2018
Q2
$25.6M Buy
88,346
+5,026
+6% +$1.41M 0.14% 151
2018
Q1
$22.8M Buy
83,320
+6,037
+8% +$1.87M 0.12% 160
2017
Q4
$24.6M Buy
77,283
+1,838
+2% +$590K 0.13% 156
2017
Q3
$23.6M Buy
75,445
+966
+1% +$286K 0.13% 155
2017
Q2
$20.2M Buy
74,479
+2,527
+4% +$668K 0.12% 174
2017
Q1
$19.7M Buy
71,952
+29,406
+69% +$8.31M 0.12% 169
2016
Q4
$12.1M Sell
42,546
-4,147
-9% -$1.23M 0.08% 210
2016
Q3
$14.6M Sell
46,693
-6,351
-12% -$1.88M 0.09% 197
2016
Q2
$12.8M Sell
53,044
-37,857
-42% -$9.98M 0.09% 201
2016
Q1
$23.7M Sell
90,901
-1,026
-1% -$271K 0.16% 138
2015
Q4
$28.2M Buy
91,927
+9,308
+11% +$2.67M 0.19% 121
2015
Q3
$24.1M Buy
82,619
+10,872
+15% +$3.59M 0.16% 130
2015
Q2
$29M Sell
71,747
-5,439
-7% -$2.18M 0.17% 116
2015
Q1
$32.6M Buy
77,186
+946
+1% +$373K 0.2% 103
2014
Q4
$25.9M Sell
76,240
-1,333
-2% -$431K 0.16% 124
2014
Q3
$25.7M Buy
77,573
+56,303
+265% +$18.6M 0.16% 113
2014
Q2
$6.71M Buy
21,270
+9,730
+84% +$2.93M 0.28% 75
2014
Q1
$3.53M Sell
11,540
-417
-3% -$132K 0.15% 122
2013
Q4
$3.34M Sell
11,957
-734
-6% -$190K 0.14% 126
2013
Q3
$3.06M Sell
12,691
-2,200
-15% -$492K 0.15% 123
2013
Q2
$3.21M Buy
+14,891
New +$3.18M 0.16% 120

Other funds holding BIIB

M&T Bank's BIIB Position: Q1 2026 in Review

M&T Bank reduced its Biogen (BIIB) stake by 5.6% in Q1 2026, selling an estimated $174K and leaving 15,817 shares worth $2.9M. The position accounts for 0.01% of the portfolio, ranked #505.

M&T Bank first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.6M in Q1 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • M&T Bank held 15,817 shares of Biogen worth $2.9M as of Q1 2026.
  • M&T Bank sold 944 Biogen shares in Q1 2026, an estimated $174K.
  • Biogen made up 0.01% of M&T Bank's portfolio in Q1 2026, its #505 holding.
  • M&T Bank first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
  • M&T Bank's Biogen position peaked at $32.6M in Q1 2015.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.